Gary D. Myers
About
Gary D. Myers is a scholar working on Oncology, Genetics and Epidemiology.
According to data from OpenAlex, Gary D. Myers has authored 20 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 11 papers in Genetics and 7 papers in Epidemiology. Recurrent topics in Gary D. Myers's work include CAR-T cell therapy research (14 papers), Virus-based gene therapy research (11 papers) and Cytomegalovirus and herpesvirus research (7 papers). Gary D. Myers is often cited by papers focused on CAR-T cell therapy research (14 papers), Virus-based gene therapy research (11 papers) and Cytomegalovirus and herpesvirus research (7 papers). Gary D. Myers collaborates with scholars based in United States and Switzerland. Gary D. Myers's co-authors include Cliona M. Rooney, Helen E. Heslop, Malcolm K. Brenner, Adrian P. Gee, Hao Liu, Barbara Savoldo, Enli Liu, Heidi V. Russell, Gianpietro Dotti and Claudia Rössig and has published in prestigious journals such as Nature Medicine, Blood and Cancer Research.
In The Last Decade
Gary D. Myers
18 papers receiving 2.8k citations
Hit Papers
Peers
Gary D. Myers
Caridad Martinez United States
M. Helen Huls United States
Bambi Grilley United States
Juan F. Vera United States
Concetta Quintarelli Italy
Meng-Fen Wu United States
Marie Bleakley United States
Alana A. Kennedy‐Nasser United States
Markus Chmielewski Germany
Citations per year, relative to Gary D. Myers Gary D. Myers (= 1×)
peers
Caridad Martinez
Countries citing papers authored by Gary D. Myers
Since
Specialization
Citations
This map shows the geographic impact of Gary D. Myers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary D. Myers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary D. Myers more than expected).
Fields of papers citing papers by Gary D. Myers
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Gary D. Myers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary D. Myers. The network helps show where Gary D. Myers may publish in the future.
Co-authorship network of co-authors of Gary D. Myers
This figure shows the co-authorship network connecting the top 25 collaborators of Gary D. Myers. A scholar is included among the top collaborators of Gary D. Myers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary D. Myers. Gary D. Myers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Qayed, Muna, Joseph P. McGuirk, Gary D. Myers, et al.. (2022). Leukapheresis guidance and best practices for optimal chimeric antigen receptor T-cell manufacturing. Cytotherapy. 24(9). 869–878.
2.
Myers, Gary D., Michael R. Verneris, André Goy, & Richard T. Maziarz. (2021). Perspectives on outpatient administration of CAR-T cell therapy in aggressive B-cell lymphoma and acute lymphoblastic leukemia. Journal for ImmunoTherapy of Cancer. 9(4). e002056–e002056.
3.
Yin, Dwight E., Rakesh K. Goyal, Atif Ahmed, et al.. (2021). Tisagenlecleucel infusion in patients with relapsed/refractory ALL and concurrent serious infection. Journal for ImmunoTherapy of Cancer. 9(1). e001225–e001225.
4.
Chaudhury, Anwesha, Andrew M. Stein, Stephan A. Grupp, et al.. (2021). Abstract 509: Conversion of cellular kinetic data for chimeric antigen receptor T-cell therapy (CAR-T) into interpretable units. Cancer Research. 81(13_Supplement). 509–509.
5.
Boyer, Michael W., Sonali Chaudhury, Kara L. Davis, et al.. (2021). ALL-026: Evaluating Efficacy and Safety of Tisagenlecleucel Reinfusion Following Loss of B-Cell Aplasia in Pediatric and Young Adult Patients with Acute Lymphoblastic Leukemia: HESTER Phase II Study. Clinical Lymphoma Myeloma & Leukemia. 21. S262–S263.
6.
Grupp, Stephan A., John E. Levine, Michael A. Pulsipher, et al.. (2021). Abstract 510: Impact of tisagenlecleucel product attributes on clinical outcomes in pediatric and young adult patients with relapsed or refractory acute lymphoblastic leukemia (r/r ALL). Cancer Research. 81(13_Supplement). 510–510.
7.
DeSimone, Robert A., Gary D. Myers, Erin Guest, & Patricia A. Shi. (2018). Combined heparin/acid citrate dextrose solution A anticoagulation in the Optia continuous mononuclear cell protocol for pediatric lymphocyte apheresis. Journal of Clinical Apheresis. 34(4). 487–489.
8.
Louis, Chrystal U., Barbara Savoldo, Gianpietro Dotti, et al.. (2011). Antitumor activity and long-term fate of chimeric antigen receptor–positive T cells in patients with neuroblastoma. Blood. 118(23). 6050–6056.
9.
Leen, Ann M., Anne Christin, Gary D. Myers, et al.. (2009). Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation. Blood. 114(19). 4283–4292.
10.
Pulé, Martin, Barbara Savoldo, Gary D. Myers, et al.. (2008). Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma. Nature Medicine. 14(11). 1264–1270.
11.
Kennedy‐Nasser, Alana A., Catherine M. Bollard, Gary D. Myers, et al.. (2008). Comparable Outcome of Alternative Donor and Matched Sibling Donor Hematopoietic Stem Cell Transplant for Children with Acute Lymphoblastic Leukemia in First or Second Remission Using Alemtuzumab in a Myeloablative Conditioning Regimen. Biology of Blood and Marrow Transplantation. 14(11). 1245–1252.
12.
Ahmed, Nabil, Kathryn Leung, Howard M. Rosenblatt, et al.. (2008). Successful Treatment of Stem Cell Graft Failure in Pediatric Patients Using a Submyeloablative Regimen of Campath-1H and Fludarabine. Biology of Blood and Marrow Transplantation. 14(11). 1298–1304.
13.
Myers, Gary D., Catherine M. Bollard, Heidi L. Weiss, et al.. (2007). Reconstitution of adenovirus-specific cell-mediated immunity in pediatric patients after hematopoietic stem cell transplantation. Bone Marrow Transplantation. 39(11). 677–686.
14.
Leen, Ann M., Catherine M. Bollard, Gary D. Myers, & Cliona M. Rooney. (2006). Adenoviral Infections in Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 12(3). 243–251.
15.
Leen, Ann M., Gary D. Myers, Uluhan Sili, et al.. (2006). Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals. Nature Medicine. 12(10). 1160–1166.
16.
Leen, Ann M., Gary D. Myers, Heidi L. Weiss, et al.. (2006). T Cell Immunotherapy for Adenoviral Infections of Stem Cell Transplant Recipients.. Blood. 108(11). 591–591.
17.
Carrum, George, Gary D. Myers, Catherine M. Bollard, et al.. (2005). Cytomegalovirus (CMV) infections and CMV-specific cellular immune reconstitution following reduced intensity conditioning allogeneic stem cell transplantation with Alemtuzumab. Bone Marrow Transplantation. 36(9). 797–802.
18.
Leen, Ann M., Gary D. Myers, Catherine M. Bollard, et al.. (2005). T‐Cell Immunotherapy for Adenoviral Infections of Stem‐Cell Transplant Recipients. Annals of the New York Academy of Sciences. 1062(1). 104–115.
19.
Myers, Gary D., Robert A. Krance, Heidi L. Weiss, et al.. (2005). Adenovirus infection rates in pediatric recipients of alternate donor allogeneic bone marrow transplants receiving either antithymocyte globulin (ATG) or alemtuzumab (Campath). Bone Marrow Transplantation. 36(11). 1001–1008.
20.
Cook, L. S., et al.. (1984). Cardiovascular parameters after acute myocardial infarction and streptokinase administration in patients receiving coronary artery bypass grafts. The American Journal of Surgery. 148(6). 860–863.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Caridad Martinez Breakdown of academic impact, for papers by M. Helen Huls Breakdown of academic impact, for papers by Bambi Grilley Breakdown of academic impact, for papers by Juan F. Vera Breakdown of academic impact, for papers by Concetta Quintarelli Breakdown of academic impact, for papers by Meng-Fen Wu Breakdown of academic impact, for papers by Marie Bleakley Breakdown of academic impact, for papers by Alana A. Kennedy‐Nasser Breakdown of academic impact, for papers by Maria Teresa Lupo Stanghellini Breakdown of academic impact, for papers by Markus Chmielewski